Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad
Authors
Keywords
-
Journal
APOPTOSIS
Volume 17, Issue 4, Pages 388-399
Publisher
Springer Nature
Online
2011-12-16
DOI
10.1007/s10495-011-0687-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unknown
- (2011) Mark Ledesma et al. MOLECULAR MEDICINE
- Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD
- (2010) Kerstin Grund et al. CANCER BIOLOGY & THERAPY
- The BH3 Mimetic ABT-737 Induces Cancer Cell Senescence
- (2010) Jin H. Song et al. CANCER RESEARCH
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- ARC Synergizes with ABT-737 to Induce Apoptosis in Human Cancer Cells
- (2010) U. G. Bhat et al. MOLECULAR CANCER THERAPEUTICS
- ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin-Based Proteins to the Cell Cytosol
- (2010) R. Traini et al. MOLECULAR CANCER THERAPEUTICS
- Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit
- (2009) L. Wang et al. Cancer Prevention Research
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis
- (2009) C. Morel et al. MOLECULAR AND CELLULAR BIOLOGY
- The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) Reveals the Need for Better Understanding of Selenium Biology
- (2009) D. L. Hatfield et al. MOLECULAR INTERVENTIONS
- RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway
- (2009) Angela M. Keuling et al. PLoS One
- Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite
- (2008) Guang-xun Li et al. CARCINOGENESIS
- Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?
- (2008) V Labi et al. CELL DEATH AND DIFFERENTIATION
- Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
- (2008) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737
- (2008) K. Okumura et al. CLINICAL CANCER RESEARCH
- Methylseleninic Acid Enhances Taxane Drug Efficacy against Human Prostate Cancer and Down-Regulates Antiapoptotic Proteins Bcl-XL and Survivin
- (2008) H. Hu et al. CLINICAL CANCER RESEARCH
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
- (2008) Scott M. Lippman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started